Rainbow Crops Awarded $7 Million Grant to Advance Climate-Resilient Crops

Ghent, Belgium - 4 March 2026 - Rainbow Crops, a next-generation agtech company developing crop genetics with enhanced complex agronomic traits, has been awarded a $7 million grant from the Gates Foundation. The funding will support the application of Rainbow Crops’ Trait Foundry™ platform to advance new genetic approaches for improving crop performance under heat and drought stress to meet the needs of smallholder farmers.

With the aim of progressing climate-resilient crops and improved germplasm delivery, the platform will develop innovative approaches for identifying and combining alleles to support germination under challenging climatic conditions.

Rainbow Crops’ Trait Foundry™ platform integrates multiplex genome editing, AI, breeding, and phenotyping to enable the systematic identification and combination of optimized genetic variants underlying complex agronomic traits. Unlike traditional breeding or single-gene approaches, the platform is designed to address traits controlled by multiple interacting genes, such as drought tolerance and plant vigor.

The research will initially focus on corn, sorghum, and rice - crops that are important to global food security, particularly in Sub-Saharan Africa and South Asia. The project places a strong emphasis on seedling performance under heat and drought stress, generating both scientific knowledge and trait-building blocks that can support future breeding efforts.

Rainbow Crops’ technology platform builds on years of research at VIB, a leading life sciences research institute, where the underlying scientific work was developed. As part of this collaboration, Rainbow Crops will work with the Lab of Professor Hilde Nelissen, from which Rainbow Crops was spun off, as well as with the VIB Transformation Facility & VIB Agro-Incubator.

Giacomo Bastianelli, Co-founder and CEO of Rainbow Crops, said, “This grant allows us to further strengthen our technology platform and contribute foundational advances that enable more climate-resilient crops, with relevance to regions most vulnerable to environmental change.”

The platform has already been validated end-to-end in corn, demonstrating the feasibility of Rainbow Crops’ multiplex genome editing and discovery approach across multiple traits. In addition, Rainbow Crops will collaborate with other industry partners, including coordination on scientific approaches and data sharing to accelerate collective progress.

 

About Rainbow Crops

Rainbow Crops is a next-generation agtech company developing climate-resilient, high-performing crop varieties through its proprietary Trait Foundry™ platform. By integrating multiplex genome editing, artificial intelligence, precision breeding, and automated phenotyping, Rainbow Crops enables the systematic engineering of complex agronomic traits. The company collaborates with seed and breeding partners to advance sustainable agriculture and global food security. Founded in 2025 as a spin-off from the VIB–UGent Center for Plant Systems Biology, Rainbow Crops builds on years of publicly supported research and operates within VIB’s advanced research infrastructure.

Learn more at www.rainbowcrops.com

 

 

 

 

 

Share

Latest stories

Website preview
Researchers identify a key biological tipping point in Alzheimer’s disease
Leuven, 4 June 2026 – Researchers from VIB, KU Leuven, the UK-DRI and Muna Therapeutics, funded by, among others, ERC, have uncovered a critical biological transition that may determine whether Alzheimer’s disease pathology leads to dementia. Studying brain tissue from older adults with and without cognitive decline, as well as cognitively healthy centenarians, the team identified distinct cellular programs and immune-cell states associated with disease progression and resilience. Their findings, published in Nature Medicine, suggest that changes in microglia—the brain’s resident immune cells—could represent an important target for future Alzheimer’s therapies.
press.vib.be
Website preview
Prof. Diether Lambrechts (KU Leuven/VIB) receives the Francqui-Collen Prize 2026
Brussels, June 2, 2026 – Prof. Dr. Diether Lambrechts (KU Leuven/VIB) and Prof. Dr. Patrice Cani (UCLouvain) are the laureates of the Francqui-Collen Prize 2026, one of the highest scientific distinctions in Belgium. Today, they receive the award from the hands of King Philippe. Prof. Lambrechts is being honored for his groundbreaking genetic research into cancer treatments, while Prof. Cani is recognized for his discoveries regarding the impact of gut bacteria on lifestyle-related diseases.
press.vib.be
Website preview
Comprehensive atlas maps dendritic cells across cancers
Brussels, 01 June 2026 — Researchers from VIB, VUB, and an international network of collaborators have created the most comprehensive single-cell atlas to date of tumor-associated dendritic cells. By integrating data from 14 mouse tumor models and 10 human cancer types, the study provides a detailed, cross-species view of how these key immune cells are organized and altered in cancer. This work, which appeared in Nature Communications, can guide the development of next-generation therapies.
press.vib.be

About VIB Press

VIB is an independent research institute that translates insights in biology into impactful innovations for society. Collaborating with the five Flemish universities, it conducts research in plant biology, cancer, neuroscience, microbiology, inflammatory diseases, artificial intelligence and more. VIB connects science with entrepreneurship and stimulates the growth of the Flemish biotech ecosystem. The institute contributes to solutions for societal challenges such as new methods for diagnostics and treatments, as well as innovations for agriculture. 

Learn more at www.vib.be.

Contact

Suzanne Tassierstraat 1 9052 Zwijnaarde

+32 9 244 66 11

press@vib.be

vib.be